- Home
- ERAS vs PFIS Comparison
ERAS vs PFIS Comparison
Compare ERAS & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- PFIS
- Stock Information
- Founded
- ERAS 2018
- PFIS 1905
- Country
- ERAS United States
- PFIS United States
- Employees
- ERAS N/A
- PFIS N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- PFIS Major Banks
- Sector
- ERAS Health Care
- PFIS Finance
- Exchange
- ERAS Nasdaq
- PFIS Nasdaq
- Market Cap
- ERAS 439.7M
- PFIS 523.7M
- IPO Year
- ERAS 2021
- PFIS N/A
- Fundamental
- Price
- ERAS $2.44
- PFIS $48.08
- Analyst Decision
- ERAS Buy
- PFIS
- Analyst Count
- ERAS 6
- PFIS 0
- Target Price
- ERAS $3.67
- PFIS N/A
- AVG Volume (30 Days)
- ERAS 2.1M
- PFIS 19.8K
- Earning Date
- ERAS 11-07-2025
- PFIS 10-23-2025
- Dividend Yield
- ERAS N/A
- PFIS 5.12%
- EPS Growth
- ERAS N/A
- PFIS 39.41
- EPS
- ERAS N/A
- PFIS 3.35
- Revenue
- ERAS N/A
- PFIS $165,604,000.00
- Revenue This Year
- ERAS N/A
- PFIS $70.81
- Revenue Next Year
- ERAS N/A
- PFIS $4.92
- P/E Ratio
- ERAS N/A
- PFIS $14.37
- Revenue Growth
- ERAS N/A
- PFIS 82.33
- 52 Week Low
- ERAS $1.01
- PFIS $38.90
- 52 Week High
- ERAS $3.31
- PFIS $59.70
- Technical
- Relative Strength Index (RSI)
- ERAS 59.41
- PFIS 49.69
- Support Level
- ERAS $2.18
- PFIS $47.10
- Resistance Level
- ERAS $2.65
- PFIS $48.22
- Average True Range (ATR)
- ERAS 0.15
- PFIS 1.17
- MACD
- ERAS -0.03
- PFIS 0.30
- Stochastic Oscillator
- ERAS 55.79
- PFIS 94.45
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.